No buy transactions available for this period
Pfizer INC filed its 13F report for Q4 2025 on February 12, 2026. The portfolio totaled 236.46 M reflecting a -45.94% change from the prior quarter, spanning 18 assets. The top 10 holdings comprised 95.4% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 0 new positions and 3 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Pfizer submitted their Form 13F-HR for the Q4 2025 period on 02/12/2026. This was the only submission for the quarter.
In the Q4 2025 filing, Pfizer reported a managed portfolio value of 236.46 M, consisting of 21 individual positions.
This page displays the raw filing documents. To see which stocks Pfizer bought or sold during Q4 2025, please visit Pfizer's Portfolio Analysis page.